Howard Lee

Howard Lee

Directeur Général chez TAHO PHARMACEUTICALS LTD.

Fortune : 3 M $ au 31/05/2026

64 ans
Health Technology
Finance
Consumer Services

Profil

Howard Lee currently works at TAHO Pharmaceuticals Ltd., as Chairman & Chief Executive Officer from 2020, Transwell Biotech Co. Ltd., as Chairman, Waterstone Pharmaceuticals, Inc., as Director, CryptoComm Partners LP, as Director, Amphastar Pharmaceuticals, Inc., as Independent Director from 2007, Sunko Ink Co., Ltd., as Independent Director from 2016, Genovate Biotechnology Co., Ltd., as Independent Director from 2020, Development Center for Biotechnology, as Director, Easywell Biomedicals, Inc., as Director, TaiMed Biologics, Inc., as Independent Director from 2017, Epoch Foundation, as Director-Supervisory Board, Association of Technology Managers In Taiwan, as Director-Supervisory Board, and Magnifica, Inc., as Director.
Dr. Lee also formerly worked at CDIB Biotech USA Investment Co. Ltd., as President & Chief Executive Officer from 2000 to 2006, International Medication Systems Ltd., as Director from 1998 to 2002, Optimer Pharmaceuticals LLC, as Director, AVIVA Biosciences Corp., as Director, InnoPharmax, Inc., as Director, OBI Pharma, Inc., as Director, Silver Biotech Management, Inc., as Managing Director from 2006 to 2009, Kuo Ching Chemical Co., Ltd., as Independent Director from 2011 to 2018, CapsoVision, Inc., as Director, CDIB Capital Group, as Vice President from 1995 to 2006, UniMed Venture Management, Inc., as Chief Investment Officer from 2009 to 2010, and The CID Group (China), as Partner from 2012 to 2020.
Dr. Lee received his graduate degree in 1990 and doctorate degree in 1990 from the University of Southern California and undergraduate degree from Fu Jen Catholic University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
02/06/2026 159 350 ( 0,36 % ) 3 M $ 31/05/2026

Postes actifs de Howard Lee

SociétésPosteDébut
EASYWELL BIOMEDICALS, INC. Directeur/Membre du Conseil -
AMPHASTAR PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/08/2007
TAHO PHARMACEUTICALS LTD. Directeur Général 10/03/2014
GENOVATE BIOTECHNOLOGY CO., LTD. Directeur/Membre du Conseil 10/06/2014
TAIMED BIOLOGICS INC. Directeur/Membre du Conseil 26/05/2017
SUNKO INK CO., LTD. Directeur/Membre du Conseil 04/05/2016
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Président -
░░░░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Howard Lee

SociétésPosteFin
░░░ ░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Howard Lee

Formation de Howard Lee

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

77

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées27

Health Technology

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Health Services

Health Technology

Process Industries

Health Technology

Epoch Foundation

UniMed Venture Management, Inc.

Health Technology

Consumer Services

Health Technology

Health Technology

CDIB Biotech USA Investment Co. Ltd.

Silver Biotech Management, Inc.

Electronic Technology

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Howard Lee
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇